arBtrage CAPITALIZING MARKETS checking… Sign in

Cingulate Inc.

CING Health Care Biotechnology: Pharmaceutical Preparations
$4.50
▼ -6.3% Today
as of Jun 7, 07:09 ET
Last 30 days -3.95% Apr 28 → Jun 05
$3.46 $3.97 $4.48 $5.00 $5.51 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.75
High
$4.75
Low
$4.32
Volume
$359,737
Avg Vol
$318,975
Mkt Cap
$58M
P/E (TTM)
Beta
52w High
$11.89
52w Low
$3.16
Div Yield
Shares Out
$12M

Overview

52-week range
$3.16
$12
15% of range
Avg surprise (last 2)
-41.6%
Avg reaction (last 2)
-3.5%
50% positive
Latest IV / EM
217%
EM ±30.0% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-72.60$-54.20$-35.80$-17.40$1.00 Actual $-6.79Actual $-72.60Actual $-7.21Actual $-5.47Actual $-2.34Actual $-1.04Est $1.00Actual $-1.09Actual $-1.35Actual $-0.95Est $-0.53 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-9M$-8M$-6M$-5M$-3M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.95 $-0.53 -79.2% +8.7% -10.8% earnings
Tue Sep 30, 2025Sep 2025 $-1.35 financials
Mon Jun 30, 2025Jun 2025 $-1.09 financials
Thu May 8, 2025Mar/2025 $-1.04 $1.00 -4.0% +3.8% earnings
Mon Sep 30, 2024Sep 2024 $-2.34 financials
Sun Jun 30, 2024Jun 2024 $-5.47 financials
Sun Mar 31, 2024Mar 2024 $-7.21 financials
Sat Sep 30, 2023Sep 2023 $-72.60 financials
Fri Jun 30, 2023Jun 2023 $-6.79 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-8M$-6M$-5M$-4M$-3M$-3M
Net income$-9M$-7M$-5M$-4M$-4M$-3M
EPS (diluted)$-0.95$-1.35$-1.09$-1.06$-2.34$-5.47

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$26M$11M$6M$9M$10M$12M$10M$380,928
Inventory
Total current assets$28M$12M$7M$10M$11M$13M$11M$3M
Total assets$31M$15M$11M$13M$12M$15M$14M$5M
Long-term debt
Total liabilities$12M$13M$7M$8M$7M$7M$2M$2M
Total equity$19M$3M$3M$6M$6M$7M$12M$3M

Implied volatility — last 90 days

211%214%216%219%221% Jun 07 — IV 217% · EM ±30.0%

Sector peers